Functional transcriptomic annotation and protein–protein interaction network analysis identify NEK2, BIRC5, and TOP2A as potential targets in obese patients with luminal A breast cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Functional transcriptomic annotation and protein–protein interaction network analysis identify NEK2, BIRC5, and TOP2A as potential targets in obese patients with luminal A breast cancer
Authors
Keywords
Breast cancer, Transcriptomic analysis, Protein–protein interaction, Clinical outcome, Novel druggable targets, Targeted therapy
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 168, Issue 3, Pages 613-623
Publisher
Springer Nature
Online
2018-01-12
DOI
10.1007/s10549-017-4652-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer
- (2017) Xi Sun et al. MEDICINE
- FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes
- (2017) Sebastien Rinaldetti et al. Oncotarget
- BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy
- (2016) A. S. Hamy et al. BREAST CANCER RESEARCH AND TREATMENT
- Transcriptomic analyses identify association between mitotic kinases, PDZ-binding kinase and BUB1, and clinical outcome in breast cancer
- (2016) Alberto Ocaña et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeting NEK2 as a promising therapeutic approach for cancer treatment
- (2016) Yanfen Fang et al. CELL CYCLE
- Recent updates on the application of protein-protein interaction network in drug discovery
- (2016) Alexiou Athanasios et al. CURRENT DRUG METABOLISM
- In Silico Analysis Guides Selection of BET Inhibitors for Triple-Negative Breast Cancer Treatment
- (2016) J. Perez-Pena et al. MOLECULAR CANCER THERAPEUTICS
- In silico analyses identify gene-sets, associated with clinical outcome in ovarian cancer: role of mitotic kinases
- (2016) Alberto Ocaña et al. Oncotarget
- Discovering gene re-ranking efficiency and conserved gene-gene relationships derived from gene co-expression network analysis on breast cancer data
- (2016) Marilena M. Bourdakou et al. Scientific Reports
- The proportion of postmenopausal breast cancer cases in the Netherlands attributable to lifestyle-related risk factors
- (2015) W. A. van Gemert et al. BREAST CANCER RESEARCH AND TREATMENT
- Global Cancer Incidence and Mortality Rates and Trends--An Update
- (2015) L. A. Torre et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
- (2015) Giovanni Ciriello et al. CELL
- Secreted factors derived from obese visceral adipose tissue regulate the expression of breast malignant transformation genes
- (2015) A B Crujeiras et al. INTERNATIONAL JOURNAL OF OBESITY
- Targeting Mitosis in Cancer: Emerging Strategies
- (2015) Carmen Dominguez-Brauer et al. MOLECULAR CELL
- DGIdb 2.0: mining clinically relevant drug–gene interactions
- (2015) Alex H. Wagner et al. NUCLEIC ACIDS RESEARCH
- Noncanonical Wnt Signaling Promotes Obesity-Induced Adipose Tissue Inflammation and Metabolic Dysfunction Independent of Adipose Tissue Expansion
- (2014) José J. Fuster et al. DIABETES
- The effects of diet induced obesity on breast cancer associated pathways in mice deficient in SFRP1
- (2014) Kelly J Gauger et al. Molecular Cancer
- Prime movers: the mechanochemistry of mitotic kinesins
- (2014) Robert A. Cross et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Targeting Survivin in Cancer: Novel Drug Development Approaches
- (2013) Bernd Groner et al. BIODRUGS
- A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer
- (2013) Zsuzsanna Mihály et al. BREAST CANCER RESEARCH AND TREATMENT
- NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other Cancers
- (2013) Wen Zhou et al. CANCER CELL
- Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells
- (2013) P Cappello et al. ONCOGENE
- Role of epidermal growth factor receptor in breast cancer
- (2012) Hiroko Masuda et al. BREAST CANCER RESEARCH AND TREATMENT
- Stromal cells in tumor microenvironment and breast cancer
- (2012) Yan Mao et al. CANCER AND METASTASIS REVIEWS
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression
- (2011) Paolo Cirri et al. CANCER AND METASTASIS REVIEWS
- Using graph theory to analyze biological networks
- (2011) Georgios A Pavlopoulos et al. BioData Mining
- The landscape of somatic copy-number alteration across human cancers
- (2010) Rameen Beroukhim et al. NATURE
- Outcome of Patients With Early-Stage Breast Cancer Treated With Doxorubicin-Based Adjuvant Chemotherapy As a Function ofHER2andTOP2AStatus
- (2009) Raymond Tubbs et al. JOURNAL OF CLINICAL ONCOLOGY
- Antimitotic effect of the retinoid 4-oxo-fenretinide through inhibition of tubulin polymerization: a novel mechanism of retinoid growth-inhibitory activity
- (2009) V. Appierto et al. MOLECULAR CANCER THERAPEUTICS
- Nek2 as a novel molecular target for the treatment of breast carcinoma
- (2008) Nobuyuki Tsunoda et al. CANCER SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search